Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors
- 1 November 2009
- journal article
- Published by Elsevier BV in Analytical Biochemistry
- Vol. 394 (1), 56-61
- https://doi.org/10.1016/j.ab.2009.07.025
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failureExpert Opinion on Pharmacotherapy, 2007
- Investigation of aldosterone-synthase inhibition in ratsJournal of Hypertension, 2006
- Synthesis and Evaluation of Heteroaryl-Substituted Dihydronaphthalenes and Indenes: Potent and Selective Inhibitors of Aldosterone Synthase (CYP11B2) for the Treatment of Congestive Heart Failure and Myocardial FibrosisJournal of Medicinal Chemistry, 2006
- Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ DamageCirculation, 2005
- Synthesis and Evaluation of (Pyridylmethylene)tetrahydronaphthalenes/-indanes and Structurally Modified Derivatives: Potent and Selective Inhibitors of Aldosterone SynthaseJournal of Medicinal Chemistry, 2005
- Synthesis and Evaluation of Imidazolylmethylenetetrahydronaphthalenes and Imidazolylmethyleneindanes: Potent Inhibitors of Aldosterone SynthaseJournal of Medicinal Chemistry, 2004
- Synthesis of Amidinohydrazones and Evaluation of Their Inhibitory Effect towards Aldosterone Synthase (CYP11B2) and the Formation of Selected SteroidsArchiv der Pharmazie, 2004
- Disorders of mineralocorticoid synthesisBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999
- Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitorsPharmacogenetics, 1995